SCHEMBL22790776

SCHEMBL22790776

CCCCOCCCCN1CCN(Cc2ccc(C)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.57
NPC1 O15118 3/20 0.57
ALDH1A1 P00352 3/20 0.57
TP53 P04637 2/20 0.57
HPGD P15428 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
GAA P10253 1/20 0.56
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
TSHR P16473 1/20 0.51
CYP2D6 P10635 1/20 0.50
HRH3 Q9Y5N1 3/20 0.49
ACHE P22303 1/20 0.48
RAD52 P43351 1/20 0.48
HRH1 P35367 1/20 0.47
PLA2G2A P14555 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22790783 0.96 ALDH1A1 (0.58) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22793928 0.94 ALDH1A1 (0.57) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL24514229 0.90 RAB9A (0.58) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22802252 0.88 ALDH1A1 (0.66) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22794081 0.87 RAB9A (0.56) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22802254 0.86 ALDH1A1 (0.64) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22790774 0.86 ALDH1A1 (0.68) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22795022 0.85 RAB9A (0.53) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL25110173 0.84 ALDH1A1 (0.58) RAB9ANPC1ALDH1A1TP53HPGD
SCHEMBL22790778 0.83 RAB9A (0.57) RAB9ANPC1ALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022125804-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed
WO-2020251972-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-17 WO disclosed
WO-2020251971-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-17 WO disclosed